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The Immuno-Regulatory Impact of Orally-Administered Hypericum
perforatum Extract on Balb/C Mice Inoculated with H1n1 Influenza A
Virus
Abstract
Hypericum perforatum (H. perforatum) ethanol extract has been found to inhibit lipopolysaccharide-induced
production of inflammatory mediators and cytokines in cultured macrophages. Therefore, it may be able to
protect the host from excessive inflammation during viral infection. In the current study, the immune-
regulatory effect of H. perforatum extract was evaluated in A549 lung epithelial cells and BALB/c mice
exposed to Influenza A/PR/8/34 H1N1 virus. In A549 cells, the extract (30 µg/mL) significantly inhibited
influenza virus induced monocyte chemotactic protein (MCP)-1 and interferon-γ induced protein 10 kD
(IP-10), but dramatically increased interleukin-6 (IL-6). In mice inoculated intranasally with 107.9 EID50 of
Influenza A/PR/8/34 H1N1 (high dose), daily oral treatment of H. perforatum extract at a rate of 110 mg/kg
of body weight increased lung viral titer, bronchoalveolar lavage (BAL) proinflammatory cytokine and
chemokine levels, and the infiltration of pro-inflammatory cells in the lung 5 days postinoculation, as
compared to ethanol vehicle treated mice. Transcription of suppressor of cytokine signaling 3 (SOCS3) was
increased by H. perforatum extract both in A549 cells and BALB/c mice, which could have interrupted anti-
viral immune response and thus led to the inefficient viral clearance and increased lung inflammation. H.
perforatum treatment resulted in minor reduction in viral titer without affecting body weight when mice were
inoculated with a lower dose (~105.0 EID50) and H. perforatum was applied in the later phase of infection.
Mice challenged intranasally with high dose of influenza virus (107.9 EID50) suffered from a higher mortality
rate when dosed with H. perforatum extract. In conclusion, the current study showed that SOCS3 elevation
by H. perforatum may cause impaired immune defense against influenza virus infection and lead to higher
mortality.
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Abstract
Hypericum perforatum (H. perforatum) ethanol extract has been found to inhibit lipopolysaccharide-induced
production of inflammatory mediators and cytokines in cultured macrophages. Therefore, it may be able to protect the
host from excessive inflammation during viral infection. In the current study, the immune-regulatory effect of H.
perforatum extract was evaluated in A549 lung epithelial cells and BALB/c mice exposed to Influenza A/PR/8/34
H1N1 virus. In A549 cells, the extract (30 µg/mL) significantly inhibited influenza virus induced monocyte chemotactic
protein (MCP)-1 and interferon-γ induced protein 10 kD (IP-10), but dramatically increased interleukin-6 (IL-6). In
mice inoculated intranasally with 107.9 EID50 of Influenza A/PR/8/34 H1N1 (high dose), daily oral treatment of H.
perforatum extract at a rate of 110 mg/kg of body weight increased lung viral titer, bronchoalveolar lavage (BAL) pro-
inflammatory cytokine and chemokine levels, and the infiltration of pro-inflammatory cells in the lung 5 days post-
inoculation, as compared to ethanol vehicle treated mice. Transcription of suppressor of cytokine signaling 3
(SOCS3) was increased by H. perforatum extract both in A549 cells and BALB/c mice, which could have interrupted
anti-viral immune response and thus led to the inefficient viral clearance and increased lung inflammation. H.
perforatum treatment resulted in minor reduction in viral titer without affecting body weight when mice were
inoculated with a lower dose (~105.0 EID50) and H. perforatum was applied in the later phase of infection. Mice
challenged intranasally with high dose of influenza virus (107.9 EID50) suffered from a higher mortality rate when
dosed with H. perforatum extract. In conclusion, the current study showed that SOCS3 elevation by H. perforatum
may cause impaired immune defense against influenza virus infection and lead to higher mortality.
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Introduction
Influenza virus has been a major public health burden for
centuries, affecting 10-20% of the general population and
causing approximately 36,000 deaths annually in the United
States [1,2]. Despite enormous vaccination efforts, influenza
seasons persist and a much feared potential outbreak of
pandemic influenza like the one in 1918 could result in a
mortality of over 80 million according to statistical predictions
using regression analysis [1]. Upon contracting influenza virus,
the host immune system is activated to contain and resolve the
infection. Respiratory epithelial cells secrete a wide variety of
pro-inflammatory cytokines and chemokines that attract and
activate innate immune cells, which subsequently initiate
adaptive immune mechanisms to clear viral particles [3-5].
Although cytokines can inhibit viral replication and are critical
for the immune response, pro-inflammatory cytokines and
inflammatory immune cells also contribute to pneumonia and
tissue damage [6]. Certain strains of influenza virus, such as
H5N1, are more likely to induce excessive cytokine release and
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immune cell exudation [4]. This so-called ‘cytokine storm’
scenario, features elevated levels of cytokines and chemokines
such as tumor necrosis factor (TNF)-α, interleukin (IL)-6,
monocyte chemotactic protein (MCP)-1, and interferon (IFN)-γ,
as well as the exudation of monocytes, macrophages, and
neutrophils. ‘Cytokine storm’ causes tissue damage, impairs
normal mucosal membrane and may induce airway blockage,
making it a risk factor for the higher mortality associated with
these virulent strains [7,8]. Therefore, alleviating inflammation
during influenza virus infection could potentially be beneficial.
Hypericum perforatum (H. perforatum) is a perennial
medicinal plant primarily used by patients with depression
disorders [9]. Its ethanol extracts have also been shown to
have anti-viral and anti-inflammatory activities [10,11]. Our
previous research demonstrated that H. perforatum ethanol
extract inhibited LPS-induced production of inflammatory
mediators including prostaglandin E2 (PGE2) and nitric oxide
(NO) in activated macrophages. One objective of this study
was to determine whether H. perforatum extract can inhibit
influenza virus-stimulated production of pro-inflammatory
cytokine and/or levels of cytokine production.
Suppressor of cytokine signaling 3 (SOCS3) is an
intracellular negative regulator of the Janus kinase-signal
transducer and activator of transcription (JAK-STAT) signaling
pathway [12]. Its function has been described as inhibitory
against inflammation because it inhibits the JAK-STAT,
mitogen-activated protein kinase (MAPK) and toll-like receptor
(TLR) pathways directly or/and indirectly [13-15]. Some
evidence suggests a role of SOCS3 in IL-6 signaling [16]. IL-6,
which usually promotes pro-inflammatory TNF-α and IL-12
production in LPS-induced activated macrophages, was found
to inhibit these cytokines when the expression of SOCS3 gene
was absent. Previously, we found that SOCS3 was elevated by
treatment of macrophages with H. perforatum extract, and this
elevation may partially account for the observed anti-
inflammatory potential of four major active compounds in the
extract [17]. However, recent studies suggested that H1N1
virus suppressed the innate immune response by increasing
SOCS3 expression and the subsequent JAK-STAT signaling
inhibition in BEAS-2B cells (transformed human bronchial
epithelial cells) [18]. If this observation reflects what is seen in
vivo, SOCS3 elevation may allow higher viral titer and less
efficient viral clearance.
In the current study, we addressed the impact of H.
perforatum ethanol extract on H1N1 influenza virus inoculated
human alveolar epithelial cell line A549 and BALB/c mice, with
particular focus on cytokine production, inflammatory damage,
viral titer, and SOCS3 gene alteration.
Materials and Methods
Ethics Statement
All animal usage procedures in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health and
were approved by the Iowa State University Institutional Animal
Care and Use Committee (Protocol 10-06-6238-R).
H. perforatum extract
Procurement and extraction of H. perforatum plant material
were as previously described [19]. In brief, 6 g of dry H.
perforatum (Accession PI325351) plant material, acquired from
the North Central Regional Plant Introduction Station (NCRPIS)
(Ames, IA) of the U.S. Department of Agriculture, Agricultural
Research Service (USDA/ARS) was ground and extracted with
500 mL of 95% ethanol using Soxhlet extraction. The extract
was dried and weighed before it was dissolved in pure DMSO
or 50% ethanol (both from Sigma, St. Louis, MO). Known
chemical constituents were quantified and the extract was
stored at -20 °C in the dark.
A549 epithelial cells
A549 human bronchial alveolar epithelial cells were acquired
from American Type Culture Collection (ATCC, Manassas,
VA). Cells were maintained in F12K media supplemented with
10% fetal bovine serum, 100 IU/mL penicillin/ 100 µg/mL
streptomycin, 0.25 µg/mL amphotericin B, and 50 µg/mL
gentamicin (all purchased from Life Technologies, Carlsbad,
CA).
H1N1 influenza virus
Influenza A/PR/8/34 H1N1 virus was grown in the amniotic-
allantoic sac of 10-11 day old embryonated eggs. The
haemagglutination unit (HAU) of the virus stock was 4096
HAU/0.05 ml (or 1010.45 EID50/ml).
A549 cell viral challenge and treatments
Influenza A/PR/8/34 H1N1 virus was diluted to 107.8
EID50/mL, in serum free media, and applied to A549 cells at 1 ×
106 cell/well in 24-well plates, or 4 × 106 cell/well in 6-well
plates. The volume of virus-containing media was 50 µL/well
for 24-well plates and 200 µL/well for 6-well plates. After 1 hr of
incubation, 450 µL (24-well plates) or 1.8 mL (6-well plates) of
media containing DMSO vehicle control or 30 µg/mL H.
perforatum extract in DMSO (DMSO accounted for 0.1% of the
total final volume) were added to each well and maintained
until the end of the 3-hr or 24-hr experiments, when the
supernatant or cells were collected for further analysis.
A549 cell viability determination
After the supernatant was collected CellTiter 96® AQueous
One Solution was added to the cells with fresh media
according to the manufacturer’s instruction (Promega,
Madison, WI). After 3 hours and 15 minutes of incubation,
optical absorbance (490 nm) was quantified to determine cell
viability.
ELISA for A549 cell culture supernatant
Collected supernatant samples were subjected to enzyme-
linked immunosorbent assay (ELISA) to determine IL-6, TNF-α,
MCP-1, and IP-10 levels. ELISA kits for these cytokines were
used following manufacturer’s instruction, after diluting samples
to concentrations within the range of standard curves (BD
Biosciences, Franklin Lakes, NJ).
Immuno-Regulatory by Oral Hypericum Perforatum
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Extraction of A549 cell RNA and gene transcription
measurements
A549 cells were harvested for RNA extraction using the
Trizol method [19]. RNA was subsequently purified with
RNeasy kit (Qiagen, Valencia, CA) and reverse-transcribed into
cDNA using an iScript cDNA synthesis kit, followed by gene
transcription quantification using an iCycler coupled with a
MyiQ optical module (all from BioRad, Hercules, CA). Primers
used for this quantitative real-time polymerase chain reaction
(qRT-PCR) were obtained from Integrated DNA Technologies,
Inc. (Coralville, IA). The SOCS3 primer sets were 5’-ATT CGC
CTT AAA TGC TCC CTG TCC-3’ (forward) and 5’- TGG CCA
ATA CTT ACT GGG CTG ACA-3’ (reverse); 5’-TCG ACA GTC
AGC CGC ATC TTC TTT -3’ (forward) and 5’- ACC AAA TCC
GTT GAC TCC GAC CTT-3’ (reverse) for the housekeeping
gene glyceraldehydes 3-phosphate dehydrogenase (GAPDH).
Extraction of A549 cell protein and Western blot
A549 cells were collected 24 hour after infection with virus,
and subjected to protein extraction as previously described
[19]. Western blotting was conducted using antibodies against
SOCS3 (sc-51699) and GAPDH (sc-137179, all from Santa
Cruz Biotechnology, Santa Cruz, CA) [17].
Mice and gavage treatments
Male BALB/c mice aged between 6-10 weeks were used in
this study (Charles River Laboratory, MA). Upon arrival, mice
were allowed to acclimate to the environment for 1+ week
before being subjected to the experiments. Mice were assigned
into different treatment groups randomly with body weight
equalized among groups before treatments began. Mice were
kept in individual cages at 25 °C and 40% humidity under 12-hr
light/dark cycles, with free access to normal rodent chow diet
(Harlan Teklad 2014) and tap water. Daily treatments of 5%
ethanol vehicle control, or H. perforatum extracts at different
concentrations in 150 µL of 5% ethanol were administrated
orally using 18 gauge animal feeding needles (Cadence
Science, Staunton, VA). A total of four studies were conducted.
In the two short term studies, including a 6-day (105.0 EID50 or
105.1 EID50/mouse; low viral titer) and a 5-day (107.9 EID50/
mouse; high viral titer) inoculation experiments, gavage was
conducted at the same time daily from one day before
inoculation (day -1) to the day before animal sacrifice (day 5
and day 4). Gavage was administrated from day 5 post-
inoculation (PI) to the day before the necropsy in the 10-day
low viral titer infection study (i.e., day 5 to day 9 PI). For the
high viral titer survival study, gavage was administered daily
from day -1 PI until the sacrifice of animal.
Toxicity of H. perforatum extract in BALB/c mice
Toxicity of the extract was tested by gavaging mice with 5%
ethanol, 60 mg/kg, 110 mg/kg, or 220 mg/kg body weight of H.
perforatum ethanol extract daily for 3 wks. Body weight and
food and water consumption were monitored daily over the
experiments, with heart, liver, spleen, kidney, and stomach
weight recorded at the end of the study during necropsy.
Mouse influenza viral infection and health monitoring
Mice were inoculated with A/PR/8/34 H1N1 influenza virus
on day 0 of each study. The procedure involved anesthesia
with isoflurane (VAD Anesthetic Machine from Vetamac,
Rossville, IN) followed by inoculation of 30 µL virus in saline
intranasally. Viral doses were 105.0 EID50 or 105.1 EID50 for the
low viral titer studies, and 107.9 EID50 for the high titer studies.
Daily records of mouse body weight, as well as food and water
disappearance (as crude measurement of consumption) were
collected, except on days towards the end of some studies,
when body weight loss exceeded 15%. In these cases, with the
mice being too weak to reach the food and water on the cage
top, food and water were supplied in petri dishes to allow
easier access.
Mouse illness score assessment
Mice were evaluated by an observer blinded to the
treatments for their sickness condition after inoculation using a
scoring system adopted from Murphy et al., which is based on
ruffled hair/ hunch back, eye and nose redness, and
unresponsiveness [20]. Each of the three signs was given a
score of 0 to 2 (for the most severe) according to severity. The
average of scores in three categories was used as the overall
illness score for each individual mouse.
Necropsy and bronchoalveolar lavage collection
Mice were euthanized at the end of the studies using carbon
dioxide. Blood was collected through heart puncture.
Bronchoalveolar lavage (BAL) fluid was collected and
processed for subsequent flow-cytometry, cytokine,
chemokine, and NO assays as described by Sim et al. [21].
BAL cytokine and nitric oxide measurement
BAL supernatant, collected after centrifugation, was
analyzed for cytokine and chemokine levels on a Luminex
platform (Bio-Rad) with a MILLIPLEX map mouse 32-cytokine/
chemokine multiplex kit (Millipore, Billerica, MA). The panel
included eotaxin, granulocyte colony-stimulating factor (G-
CSF), granulocyte macrophage colony-stimulating factor (GM-
CSF), IFN-γ, IL-1α, IL-1β, IL-2, IL-2, IL-4, IL-5, IL-6, IL-7, IL-9,
IL-10, IL-12 (p40), IL-12 (p70), IL-13, IL-15, IL-17, IP-10,
keratinocyte-derived cytokine (KC), leukemia inhibitory factor
(LIF), LPS-stimulated CXC chemokine (LIX), M-CSF, MCP-1,
monokine induced by IFN-γ (MIG), macrophage inflammatory
protein-1α (MIP-1α), MIP-1β, MIP-2, regulated upon activation,
normal T-cell expressed, and secreted cytokine (RANTES),
TNF-α, and vascular endothelial growth factor (VEGF). NO was
measured using Greiss reagent (Promega, Madison, WI) as
previously described [22].
BAL cell population characterization
BAL cells were stained for conjugated antibodies against
different surface proteins. Antibodies used included FITC-anti-
mouse CD8b, Alexa Fluor® 647-anti-mouse CD11b, and PE-
anti-mouse Gr1 (eBioscience, San Diego, CA). Labeled
samples, along with isotype controls, were subject to BD FACS
Canto flow cytometer analysis (BD Biosciences). Cell
Immuno-Regulatory by Oral Hypericum Perforatum
PLOS ONE | www.plosone.org 3 September 2013 | Volume 8 | Issue 9 | e76491
populations were characterized according to forward scatter,
side scatter, and fluorescent signals using FlowJo software
(Tree Star, Ashland, OR). Specifically, CD11b+, GR1+, and high
side scatter (SSC) BAL cells were considered as neutrophils in
the 6-day low viral titer study, while cytotoxic T cells were
CD8β+, and mononuclear phagocytes being GR1intermediate with
low SSC. In the 5-day high viral titer study, neutrophils were
CD11b+ and GR1+ with high SSC; cytotoxic T cells were CD8β
+; inflammatory macrophages were CD11b+and GR1- with high
auto-fluorescence [23]; resident alveolar macrophages were
CD11b- and GR1- with high auto-fluorescent; inflammatory
monocytes were CD11b+ and GR1intermediate with low SSC [24].
Lung index, histopathology score, and viral titer
quantification
Lungs were harvested from the mice and weighed in the 6-
day low viral titer and 5-day high viral titer infection studies.
Lung index, a crude measurement of lung inflammation during
infection, was calculated using the formula: (lung weight)/(body
weight) × 100 [25]. In the 10-day low viral titer infection study, 4
lobes of lung were fixed in buffered formalin (Fisher Scientific,
CA), followed by paraffin embedding. Approximately 5 µm thick
sections were stained with hematoxylin-eosin and inspected
under a light microscope. Lung histophathological lesions,
characterized by necrosis, degeneration, hyperplasia, and
infiltration, were evaluated and scored blinded to treatments
using standards previously used by Sim et al. [21]. Lung viral
titer was determined using qRT-PCR using specific primers
against conservative nucleoprotein gene as described in detail
by Sim et al. [21].
Lung RNA extraction and gene transcription
quantification
One lobe of lung from each mouse was snap-frozen upon
necropsy and ground in liquid nitrogen. The ground tissue was
combined with Trizol reagent (Invitrogen) and homogenized.
Trizol method and RNeasy (Qiagen) purification procedures
were subsequently applied to obtain purified RNA from lung
tissue. RNA samples were then reverse-transcribed into cDNA
using an iScript cDNA synthesis kit (BioRad). cDNA samples
were normalized to the same 100 ng/mL concentration before
subjection to gene transcription quantification in iCycler
coupled with a MyiQ optical module (BioRad). Primers used
were 5’-ATT CAC CCA GGT GGC TAC AG-3’ (forward) and 5’-
GCC AAT GTC TTC CCA GTG TT-3’ (reverse) for SOCS3, as
well as 5’-CAA TGT GTC CGT CGT GGA T-3’ (forward) and 5’-
AGC CCA AGA TGC CCT TCA G-3’ (reverse) for GADPH.
Mouse survival after high dose influenza virus
inoculation
Mice were monitored for their body weight during the survival
study. When body weight loss exceeded 20% of initial level, the
mouse was euthanized. Survival or mortality was assessed
until day 10 PI.
Statistical analysis
Measured A549 cell cytokine production and mRNA
transcription levels from 3 replicates of culture plates in the
same experiment were log-transformed and analyzed using
ANOVA as a randomized complete block design with cell
culture plates as fixed blocks. All treatments with or without
viral infection were compared to the media + DMSO vehicle
control. Animal study data that was repeatedly measured, such
as body weight, food and water intake, and illness score, were
analyzed using a mixed ANOVA model that included an
unspecified structure for the day to day repeat correlation. For
post-hoc tests, treatments were compared to each other on
each day after Tukey adjustment. Lung index, cell population,
lung lesion score, log-transformed cell viral titer and lung gene
transcription levels were analyzed using ANOVA test, followed
by multiple comparisons between individual treatment groups
with Tukey adjustment (SAS 9.0, SAS Institute, Cary, NC).
Survival data was analyzed by comparing Kaplan-Meier
survival curve between the vehicle control and H. perforatum
groups in SPSS (SPSS 17.0, SPSS Inc., Chicago, IL).
Results
Cytokine released by A549 lung bronchial epithelial
cells
Production of IL-6, IP-10, TNF-α, and MCP-1 by A549 cells
were drastically stimulated 24 hrs after H1N1 virus inoculation
as shown in Figure 1. In comparison to DMSO vehicle control,
H. perforatum treatment significantly increased IL-6 production
(panel A) in cells without virus inoculation, resulting in a level
even higher than that of inoculated vehicle treated cells. Virus-
induced TNF-α (panel B), IP-10 (panel C), and MCP-1 (panel
D) production were inhibited by H. perforatum extract
treatment. The background levels of IP-10 and MCP-1
produced by A549 cells were also decreased when treated with
H. perforatum extract. No apparent difference in cell viability
was found associated with virus challenge or the treatment of
extract at the 24 hr time point (Figure S1).
SOCS3 expression in A549 cells
SOCS3 gene transcription was measured in A549 bronchial
epithelial cells under the treatments of DMSO vehicle or 30
µg/mL H. perforatum extract, with and without H1N1 virus
infection. After 3 hrs of treatment, H1N1 influenza virus
significantly elevated SOCS3 transcription level in the DMSO
vehicle treated cells, the extract increased SOCS3 transcription
with or without virus as indicated by Figure 2 (Panel A).
SOCS3, relative to GAPDH housekeeping reference, was not
changed by either the treatments or virus infection at the 24 hr
time point. At protein level, SOCS3 expression was also
dramatically elevated by the H. perf extract treatment, while no
significant increase was observed after virus challenge (Panel
B). GAPDH protein expression remained unchanged in A549
cells under viral challenge or treatment.
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In vivo toxicity of H. perforatum extract
Mice gavaged with 5% ethanol vehicle control, 60 mg/kg H.
perforatum extract, 110 mg/kg extract, and 220 mg/kg extract
were monitored over the 3 week treatment regimen for their
body weights and daily food consumption. No difference in
body weight or food intake was found between these groups,
neither did they differ in liver, kidney, spleen, stomach or
intestine weight at the end of the study (data not shown). No
apparent skin lesion or behavior abnormity was observed in H.
perforatum treated groups.
Body weight, food and water disappearance, and
illness score of mice in 6-day low viral titer (105.0 EID50)
inoculation study
Daily records of body weight (Figure 3, panel A), food
(Figure 3, panel B) and water (Figure 3, panel C)
disappearance are shown from day -1 to day 6 PI, while mouse
illness scores are shown from day 1 to day 6 PI (panel D).
Body weight of virus inoculated mice started to drop on day 3
and became significantly lower than the non-inoculated group
by day 4. By day 6 PI, the discrepancy between the inoculated
and non-inoculated mice was ~2.7 g or ~12% initial body
weight. Food and water consumption, measured by daily food
and water disappearance, had similar trends as body weight,
with differences between inoculated and non-inoculated mice
becoming significant after day 4 and day 3 PI, respectively.
Inoculated mice treated with vehicle and H. perforatum extract
had the same body weight, food and water intake over the
course of the study. Illness score remained 0 during the study
in the non-inoculated group, while the scores for the inoculated
groups became significantly higher than 0 at day 4. The H.
perforatum treated group had a lower illness score than the
vehicle control treated group, although the difference was not
statistically significant, likely due to high variability (p=0.09).
Lung index and viral titer in 6-day low viral titer (105.0
EID50) inoculation study
The lung index of the mice at the end of the study are shown
in Figure 4, panel A. The lung index of the inoculated vehicle
group was significantly higher than that of the non-inoculated
group, while the H. perforatum treated group was not
significantly different from either group. Lung viral titer was
measured for each mouse. The results, depicted in panel B,
indicated relatively higher lung viral titer in the two inoculated
groups, with no significant difference between them.
Figure 1.  Cytokines released by A549 human bronchial epithelial cells.  DMSO vehicle control or 30 µg/mL H. perforatum
extract in DMSO were applied to cells, with or without H1N1 influenza virus inoculation. Cytokine levels for IL-6 (A), TNF-α (B),
IP-10 (C), and MCP-1 (D) after 24 hrs of treatment are shown as Mean ± SEM (N=3). Significant difference between vehicle and H.
perforatum extract treatments are noted with * (p<0.05).
doi: 10.1371/journal.pone.0076491.g001
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Serum inflammatory cytokines in 6-day low viral titer
(105.0 EID50) inoculation study
Inflammatory cytokines IL-6 and IL-1β in mouse serum were
measured using ELISA (Figure S2). IL-6 was elevated by H1N1
influenza viral inoculation and the H. perforatum treated group
had a significantly lower IL-6 level in comparison to the
inoculated vehicle group. No difference was found between the
three groups regarding serum IL-1β level.
Figure 2.  SOCS3 expression in A549.  A549 cells were treated with DMSO vehicle control or 30 µg/mL H. perforatum extract in
DMSO, with or without inoculation of H1N1 influenza virus. SOCS3 mRNA expression levels relative to and GAPDH (control) 3 hrs
and 24 hrs after treatment are shown as log relative transcription level (Panel A. Mean ± SEM, N=3). Protein expression of SOCS3
24 hrs after the treatment was measured using Western blot and shown in Panel B (Mean ± SEM, N=3) as percentage of vehicle
control without virus, together with a representative image. Values at the same time point are differentiated by individual letter labels
when significant differences exist (p<0.05, a > b > c).
doi: 10.1371/journal.pone.0076491.g002
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Figure 3.  Body weight, food and water disappearance, and illness score of mice in 6-day low viral titer inoculation
study.  Mice were inoculated intranasally with H1N1 influenza virus (105.0 EID50) on day 0 and gavaged with 5% ethanol vehicle
control from day -1 to day 5 PI (N=12), or inoculated with virus on day 0 and gavaged with H. perforatum extract in 5% ethanol
(N=12) at the rate of 110 mg/kg of body weight, or not inoculated with virus and gavaged with 5% ethanol (N=6). Daily records of
body weight (A), food (B) and water disappearance (C), as well as mouse illness score (D) are shown as Mean ± SEM. Significant
difference between non-inoculated and inoculated groups is labeled with * (p<0.05), while difference between inoculated vehicle and
inoculated H. perforatum extract treated group is highlighted with # (p<0.05).
doi: 10.1371/journal.pone.0076491.g003
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BAL inflammatory cytokines and NO in 6-day low viral
titer (105.0 EID50) inoculation study
BAL samples collected from the mice were subject to
multiplex analysis, and the results are shown in Table 1. All
cytokines and NO in the panel, except for eotaxin, IL-1α, IL-2,
IL-3, IL-7, IL-9, and IL12 (p40), were significantly elevated after
influenza virus inoculation. IL-2 was slightly decreased after
inoculation although its level was very low (
< 2 pg/mL). IL-6 was higher in the H. perforatum extract
treated group compared to the inoculated vehicle treated
group. The two inoculated groups did not differ from each other
in other cytokines or NO.
BAL cell population in 6-day low viral titer (105.0 EID50)
inoculation study
Cells in the BAL were analyzed using flow cytometry. Figure
5 shows the total cell counts (panel A) and percentage of
neutrophils (panel B), CTLs (panel C), as well as mononuclear
phagocytes (panel D) in the BAL. While inoculation with
influenza virus increased the total number of cells in the BAL,
the H. perforatum treated mice had somewhat lower total cell
count than the vehicle treated mice, although not statistically
significant. The percentages of neutrophils, mononuclear
phagocytes, and CTLs increased after virus inoculation when
compared to the non-inoculated mice. H. perforatum treatment
led to higher percentage and total count (1.5×104 vs. 2.1×104)
of pro-inflammatory mononuclear phagocytes, when compared
to vehicle treated mouse after infection.
Body weight, food and water disappearance, and
illness score in 5-day high viral titer (107.9 EID50)
inoculation study
Aiming to study the effect of H. perforatum on mice with
severe influenza symptoms, a high viral dose of 107.9 EID50 was
used to inoculate the animals in a 5-day infection study. Daily
body weight, food and water intake, and illness score
measurements throughout the study are shown in Figure 6.
Due to the higher viral dose, significant body weight drop
Figure 4.  Lung index and viral titer of mice.  Mice were inoculated intranasally with 105.0 and 107.9 EID50 of H1N1 influenza virus
respectively on day 0 and gavaged with 5% ethanol vehicle control from day -1 to day 6 (N=12) or day 5 PI (N=15), or inoculated
with virus on day 0 and gavaged with 110 mg/kg H. perforatum extract in 5% ethanol (N=12 for low viral titer study and N=15 for
high viral titer study), or not inoculated with virus and gavaged with 5% ethanol (N=6 for 6-day study and N=5 for 5-day study). At
the end of the study, the mouse lungs were weighed and used to calculate lung index (A and C) by histopathology, shown as Mean
± SEM. Lung viral titer (B and D) was measured using qRT-PCR, with log values for relative viral titer shown as Mean ± SEM.
Values without the same label are different from each other statistically (p<0.05, a > b > c).
doi: 10.1371/journal.pone.0076491.g004
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appeared just 2 days after inoculation and resulted in over 20%
(5 g) weight lost at the end of the 5 day study (panel A).
However, the two inoculated groups were not significantly
different in body weight. Records of food (panel B) and water
(panel C) disappearance on day 5 PI were not collected
because moistened diets were given in petri dishes to the
animals that had lost over 15% of body weight to improve
access to food and water. Food disappearance was lower in
the inoculated groups from days 2 through 4 PI. Water
disappearance was similar throughout the study between the
Table 1. Mouse BAL cytokine and NO levels in 6-day low
viral titer (105.0 EID50) inoculation study.
Cytokines
Inoculated vehicle
(N=12)
Inoculated H. perf
(N=12)
Non-
inoculated
(N=6)
Statistical
effect
    Infection
H.
perf
Eotaxin 32.1 ± 5.6 34.1 ± 5.2 13.6 ± 11.4   
G-CSF 985.7 ± 186.4 937.6 ± 148.8 1.2 ± 0.3 *  
GM-CSF 18.2 ± 2.4 15.3 ± 2.1 1.3 ± 1.3 *  
IFN-γ 2626.7 ± 687.2 2401.6 ± 504.1 0.8 ± 0.4 *  
IL-1a 11.5 ± 1.4 11.0 ± 1.7 7.5 ± 2.7   
IL-1b 10.1 ± 0.8 10.2 ± 1.4 2.4 ± 0.7 *  
IL-2 1.5 ± 0.1 1.4 ± 0.1 2.5 ± 0.5 *  
IL-3 1.4 ± 0.1 1.4 ± 0.1 1.0 ± 0.1   
IL-4 0.8 ± 0.1 0.8 ± 0.1 0.4 ± 0.0 *  
IL-5 15.5 ± 3.8 16.1 ± 3.2 0.2 ± 0.1 *  
IL-6 933.7 ± 167.0 1424.6 ± 305.9 2.7 ± 1.3 * #
IL-7 0.5 ± 0.1 0.5 ± 0.2 0.3 ± 0.2   
IL-9 98.9 ± 11.8 100.2 ± 12.2 69.8 ± 10.4   
IL-10 159.4 ± 48.0 128.1 ± 25.6 0.8 ± 0.3 *  
IL12(p40) 9.0 ± 1.0 7.6 ± 1.5 11.0 ± 2.9   
IL-12(p70) 10.2 ± 1.2 10.0 ± 1.4 0.0 ± 0.0 *  
IL-13 23.6 ± 2.6 21.2 ± 4.2 0.3 ± 0.2 *  
IL-15 8.2 ± 1.1 6.5 ± 1.4 1.1 ± 0.6 *  
IL-17 2.1 ± 0.2 2.1 ± 0.3 0.6 ± 0.2 *  
IP-10 2348.4 ± 0.3 2369.3 ± 0.4 5.8 ± 2.5 *  
KC 390.6 ± 38.2 353.0 ± 67.5 14.5 ± 2.7 *  
LIF 87.3 ± 15.4 82.9 ± 15.5 0.4 ± 0.1 *  
LIX 32.3 ± 9.2 20.9 ± 8.4 4.4 ± 4.4 *  
MCP-1 425.1 ± 100.6 426.4 ± 78.5 1.0 ± 0.7 *  
M-CSF 9.1 ± 1.0 7.6 ± 0.8 0.9 ± 0.6 *  
MIG 11271 ± 1444 11140 ± 1958 8.8 ± 2.4 *  
MIP-1a 34.5 ± 3.7 33.0 ± 4.3 4.8 ± 1.6 *  
MIP-1b 302.7 ± 55.0 299.8 ± 54.8 1.8 ± 0.9 *  
MIP-2 75.6 ± 11.2 61.2 ± 4.7 3.2 ± 2.0 *  
RANTES 15.3 ± 1.7 16.1 ± 2.4 1.7 ± 0.2 *  
TNF-α 10.7 ± 1.6 10.6 ± 1.7 1.4 ± 0.1 *  
VEGF 23.7 ± 3.3 18.5 ± 2.4 6.7 ± 1.2 *  
NO1 1.5 ± 0.3 1.2 ± 0.2 0.3 ± 0.1 *  
Data shown in pg/mL as Mean ± SEM (1NO unit is µM). Significant difference
between non-inoculated and inoculated groups is labeled with * (p<0.05), while
difference between inoculated vehicle control and inoculated H. perforatum extract
treated group is highlighted with # (p<0.05).
doi: 10.1371/journal.pone.0076491.t001
groups. More water disappeared in the virus-inoculated groups
on day 0 in comparison to the non-inoculated group. At the
same time, the H. perforatum treated group had greater water
disappearance than the virus-inoculated mice treated with
vehicle on day 1 PI. Mouse illness scores for the virus-
inoculated groups were significantly higher than that of the non-
inoculated group from day 2 through day 5 PI, with no
difference between mice treated with ethanol vehicle and H.
perforatum extract (panel D).
Lung index and viral titer in 5-day high viral titer (107.9
EID50) inoculation study
Lung index and Influenza A H1N1 viral titer for each mouse
were measured at the end of the 5 day study and are shown in
Figure 4. Both lung index (panel C) and viral titer (panel D) of
the mice challenged with influenza virus were elevated
comparing to the non-challenged group. Mice treated with H.
perforatum extract had significantly higher viral titer than that of
the vehicle treated animals after Influenza A H1N1 inoculation,
while the lung index was the same in the two inoculated
groups, both were higher than that in the non-inoculated group.
BAL inflammatory cytokines and NO in 5-day high viral
titer (107.9 EID50) inoculation study
Table 2 demonstrates the cytokines and NO levels in lung
BAL measured using multiplex. Except for IL-9, IL12 (p40), and
LIX, all cytokines plus NO were significantly elevated after
influenza virus challenge. H. perforatum treatment resulted in
higher levels of a variety of inflammatory cytokine and NO
when compared to the inoculated vehicle treated control.
Cytokines increased by H. perforatum treatment included
eotaxin, G-CSF, GM-CSF, M-CSF, IL-6, IL-12(p70), IL-13,
IL-15, LIF, MCP-1, and MIP-2. At the same time, IP-10 was
found to be reduced by H. perforatum treatment.
BAL cell population in 5-day high viral titer (107.9 EID50)
inoculation study
Total BAL cell number (panel A) and neutrophil cell
percentage (panel B) were significantly higher in the virus-
inoculated groups than in the non-inoculated groups, as shown
in Figure 7. The H. perforatum treated group had more
neutrophils and inflammatory monocytes (panel F) than the
inoculated-vehicle group, with a lower percentage of cytotoxic
T cells (panel C). Although no significant difference was found
between all three groups in the percentage of inflammatory
macrophages (panel D), the inoculated groups had higher
numbers of these cells (1.9×103 for vehicle and 2.5×103for H.
perforatum) than the non-inoculated group (1.1×103). The H.
perforatum treated mice had a slightly higher number of
inflammatory macrophages than the vehicle treated group,
although the difference was not statistically significant.
Resident macrophages accounted for a lower portion of BAL
cells in the inoculated groups than in the non-inoculated group,
but were not different between the two inoculated groups
(panel E).
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Body weight, food and water consumption, and illness
score in 10-day long term low viral titer (105.1 EID50)
inoculation study
In order to study whether administrating H. perforatum
extract during later phase of influenza virus inoculation could
alleviate inflammatory lung lesion, a 10-day inoculation study
was conducted, with gavage beginning at day 5 PI. Daily
records of body weight (Figure 8, panel A) from day 0 until day
10 PI, food (Figure 8, panel B) and water (Figure 8, panel C)
disappearance are shown from day 0 to day 7 PI. The lack of
diet and water disappearance data after day 7 PI was due to
animals being provided these in petri dishes in the cage to
allow access. Mouse illness score on day 10 PI is shown in
panel D. Body weight of these inoculated mice began
decreasing progressively by day 3 PI and body weight losses
reached ~ 16 g on average at the end of the study. No
difference in either endpoint, except for food intake on day 6 PI,
was noted between the two treatments. H. perforatum treated
mice consumed lower amount of diet on day 6 PI, but returned
to the same level as the vehicle control group on day 7 PI.
Lung lesion score and viral titer in 10-day long term low
viral titer (105.1 EID50) inoculation study
Lung lesion score and H1N1 viral titer for each mouse was
measured at the end of the 10-day study and are shown in
Figure 9. Lung lesion score was not significantly different
between the two groups, while lung viral titer of mice treated
with H. perforatum extract was slightly lower than that of the
vehicle group.
Expression of SOCS3 gene in BALB/c mouse lung
RNAs from lungs collected from the 5-day high viral titer and
10-day low viral titer studies were quantified for SOCS3 gene
expression, as demonstrated in Figure 10. SOCS3 transcription
Figure 5.  Mouse BAL cell population in 6-day low viral titer inoculation study.  Mice were inoculated intranasally with H1N1
influenza virus (105.0 EID50/mouse) on day 0 and gavaged with 5% ethanol vehicle control from day -1 to day 5 PI (N=12), or
inoculated with virus on day 0 and gavaged with 110 mg/kg H. perforatum extract (N=12), or not inoculated with virus and gavaged
with 5% ethanol (N=6). BAL cells were sorted using flow-cytometry. Total cell counts (A), and percentage of BAL cells being
neutrophils (CD11b+ GR1+ high SSC)(B), cytotoxic T cells (CD8b+ low SSC)(C) and mononuclear phagocytes (GR1int low SSC)(D)
are shown as Mean ± SEM for each treatment group. Values without same label are different from each other statistically (p<0.05, a
> b > c).
doi: 10.1371/journal.pone.0076491.g005
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Figure 6.  Body weight, food and water disappearance, and illness score of mice in 5-day high viral titer inoculation
study.  Mice were inoculated intranasally with H1N1 influenza virus (107.9 EID50) on day 0 and gavaged with 5% ethanol vehicle
control from day -1 to day 4 PI (N=15), or inoculated with virus on day 0 and gavaged with 110 mg/kg H. perforatum extract (N=15),
or not inoculated with virus and gavaged with 5% ethanol (N=6). Daily records of body weight (from day -1 to day 5)(A), food (B) and
water disappearance (C)(from day -1 to day 4), as well as mouse illness score (D)(from day 1 to day 5) are shown as Mean ± SEM.
Significant difference between non-inoculated and inoculated groups is labeled with * (p<0.05), while difference between inoculated
vehicle and inoculated H. perforatum group is highlighted with # (p<0.05).
doi: 10.1371/journal.pone.0076491.g006
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was elevated in the inoculated groups 5 days PI, and the H.
perforatum treated mice showed higher level of SOCS3 mRNA
compared to those receiving vehicle treatment. By day 10 PI,
both inoculated groups had the same SOCS3 expression level
in relation to the GAPDH housekeeping gene.
Survival curve of mice treated with H. perforatum
extract
Mice inoculated with high viral titer (107.9 EID50) of H1N1 virus
received either 5% ethanol vehicle control or H. perforatum
treatment. The survival curves under the two treatments are
shown in Figure 11. Although the body weight, food and water
disappearance were not different between the two groups (data
not shown), H. perforatum treatment led to earlier mortality as
compared to the vehicle control, as indicated by the significant
difference in the two survival curves. By day 8 PI, all mice in
the H. perforatum group were dead, while 2 mice out of 20 in
the vehicle group survived the entire 10-day observation
period.
Discussion
Our prior studies on the anti-inflammatory potential of H.
perforatum were conducted using the RAW 264.7 mouse
macrophage model [19], although these macrophages are
important in responding to infectious agents, when it comes to
influenza virus, respiratory epithelial cells are the target of
infection and are the site at which the initiation of an immune
Table 2. Mouse BAL cytokine and NO levels in 5-day high viral titer inoculation study (107.9 EID50).
Cytokines Inoculated vehicle (N=15)  Inoculated H. perf (N=15) Non-inoculated (N=6) Statistical effect
    Infection H. perf
Eotaxin 110.2 ± 23.9 194.9 ± 36.7 7.0 ± 2.0 * #
G-CSF 3.2 ± 1.1 8.5 ± 2.1 0.0 ± 0.0 * #
GM-CSF 21.4 ± 2.3 29.2 ± 2.1 0.8 ± 0.8 * #
IFN-γ 497.4 ± 212.1 378.8 ± 141.2 0.4 ± 0.3 *  
IL-1a 13.1 ± 2.1 19.2 ± 2.3 3.6 ± 2.3 *  
IL-1b 10.1 ± 1.0 8.2 ± 0.4 3.0 ± 0.4 *  
IL-2 1.5 ± 0.1 1.4 ± 0.1 2.2 ± 0.3 *  
IL-3 1.7 ± 0.1 2.0 ± 0.2 1.0 ± 0.1 *  
IL-4 0.8 ± 0.1 0.9 ± 0.1 0.4 ± 0.0 *  
IL-5 26.2 ± 7.8 39.3 ± 10.1 0.1 ± 0.0 *  
IL-6 942.8 ± 205.6 1667.8 ± 301.9 0.3 ± 0.2 * #
IL-7 0.7 ± 0.1 0.8 ± 0.1 0.2 ± 0.1 *  
IL-9 114.2 ± 15.3 120.0 ± 17.3 85.1 ± 18.3   
IL-10 75.2 ± 42.3 35.8 ± 8.3 0.1 ± 0.1 *  
IL12(p40) 6.7 ± 1.3 8.3 ± 1.4 3.3 ± 2.0   
IL-12(p70) 10.6 ± 1.9 16.4 ± 2.2 0.1 ± 0.1 * #
IL-13 22.9 ± 4.7 42.2 ± 5.8 0.0 ± 0.0 * #
IL-15 8.5 ± 1.0 13.3 ± 2.0 1.1 ± 0.5 * #
IL-17 2.1 ± 0.3 2.4 ± 0.3 0.5 ± 0.1 *  
IP-10 2434.6 ± 248.2 1614.9 ± 98.8 4.5 ± 0.7 * ˅
KC 150.7 ± 39.6 176.5 ± 24.2 11.3 ± 1.0 *  
LIF 119.2 ± 24.3 420.2 ± 98.4 0.6 ± 0.1 * #
LIX 172.4 ± 129.6 3.2 ± 1.8 0.0 ± 0.0   
MCP-1 817.8 ± 188.1 1260.4 ± 174.0 0.3 ± 0.3 * #
M-CSF 11.0 ± 1.5 16.1 ± 1.8 0.5 ± 0.4 * #
MIG 8644.9 ± 2158 10772 ± 2203 8.2 ± 2.4 *  
MIP-1a 32.1 ± 5.7 31.6 ± 0.0 5.7 ± 1.7 *  
MIP-1b 131.8 ± 30.7 149.4 ± 26.2 1.4 ± 0.7 *  
MIP-2 89.7 ± 11.8 136.1 ± 14.1 3.8 ± 1.9 * #
RANTES 15.7 ± 3.0 19.5 ± 1.9 1.3 ± 0.1 *  
TNF-α 8.2 ± 1.6 9.9 ± 1.2 1.3 ± 0.1 *  
VEGF 33.8 ± 8.7 30.2 ± 4.0 8.1 ± 1.2 *  
NO1 3.8 ± 0.5 5.1 ± 0.3 1.4 ± 0.6 * #
Data shown in pg/mL as Mean ± SEM (1NO unit is µM). Significant difference between non-inoculated and inoculated groups is labeled with * (p<0.05), while difference
between inoculated vehicle control and inoculated H. perforatum extract treated group is highlighted with # (increased in H. perforatum treated group) and ˅ (decreased in H.
perforatum treated group) (p<0.05).
doi: 10.1371/journal.pone.0076491.t002
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response occurs [26]. MCP-1 and IP-10 are released by lung
epithelial cells to recruit monocytes, NK cells and neutrophils,
while IL-6 regulates the innate immune cell functions through
the IL-6 receptor (IL-6R) [27]. In contrast to our prior
observation in lipopolysaccharide (LPS)-induced macrophages,
we found that the H. perforatum extract drastically increased
IL-6 production by A549 cells, with or without virus stimulation
(Figure 1). LPS-induced IL-6 in macrophages was decreased
Figure 7.  Mouse BAL cell population in 5-day high viral titer inoculation study.  Mice were intranasally inoculated with H1N1
(107.9 EID50) influenza virus on day 0 and gavaged with 5% ethanol vehicle control from day -1 to day 4 PI (N=15), or inoculated with
virus on day 0 and gavaged with 110 mg/kg H. perforatum extract (N=15), or not inoculated with virus and gavaged with 5% ethanol
(N=6). BAL cells were subject to flow-cytometry. Total cell counts (A), and percentage of BAL cells being neutrophils (CD11b+ GR1+
high SSC)(B), cytotoxic T cells (CD8b+ low SSC)(C), induced macrophages (CD11b+ GR1- high auto-fluorescent)(D), resident
alveolar macrophages (CD11b- GR1- high auto-fluorescent)(E) and inflammatory monocytes (CD11b+ GR1int low SSC)(F) are shown
as Mean ± SEM for each treatment group. Values without same over bar label are statistically different from each other (p<0.05, a >
b > c).
doi: 10.1371/journal.pone.0076491.g007
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Figure 8.  Body weight, food and water disappearance, and illness score of mice in 10-day long term low viral titer
inoculation study.  Mice were inoculated intranasally with H1N1 influenza virus (105.1 EID50) on day 0 and gavaged with 5%
ethanol vehicle control from day 5 to day 9 PI (N=13), or inoculated with virus (105.1 EID50) on day 0 and gavaged with 110 mg/kg H.
perforatum extract (N=13). Daily records of body weight (from day 0 to day 10), food and water disappearance (from day 1 to day 7),
as well as mouse illness score on day 10, are shown as Mean ± SEM. Significant difference between inoculated vehicle and
inoculated H. perforatum group is highlighted with # (p<0.05).
doi: 10.1371/journal.pone.0076491.g008
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by H. perforatum treatment in our previous study [28], and
decreasing IL-6 was found to be important for the anti-
depressive efficacy of H. perforatum treatment in rodents
[29,30]. At the same time, influenza virus-induced TNF-α,
MCP-1 and IP-10 production by epithelial cells were decreased
by the extract, suggesting anti-inflammatory activity similar to
what was observed in macrophages.
Influenza virus induced SOCS3 elevation in A549 cells
shortly after inoculation has been reported by Pauli et al. and
described as a mechanism through which the virus may
compromise innate immune response [18,31]. We observed
similar results in the current study, as H1N1 virus significantly
increased SOCS3 gene transcription in A549 cells 3 hrs PI. H.
perforatum extract treatment itself induced an even higher level
of SOCS3 transcription in A549 cells, with or without influenza
virus inoculation (Figure 2). The concurrence of SOCS3 and
IL-6 elevation is likely to be connected, as the IL-6R signaling
depends on JAK-STAT and SOCS3 over-expression was
shown to coincide with over-production of BAL IL-6 in mouse
lung [32]. The divergent changes in different cytokines could be
attributed to the dependence of IL-6 release on the activation of
NF-κB, which was not inhibited by H. perforatum extract
treatment, while IP-10 and MCP-1 production are activated by
the IFN-γR/IL-6R-JAK-STAT pathway, which was inhibited by
SOCS3. It should be noted that TNF-α, a primarily
inflammatory cytokine produced by macrophages, NO-
producing dendritic cells, and CD8+ T cells during influenza
virus infection, was only released by epithelial cells at a very
Figure 9.  Lung lesion score and lung viral titer in 10-day long term low viral titer inoculation study.  Mice were inoculated
intranasally with H1N1 influenza virus (105.1 EID50) on day 0 and gavaged with 5% ethanol vehicle control (N=13), or 110 mg/kg H.
perforatum extract (N=13) from day 5 to day 9 PI. Microscopic lung lesion scores are shown in box plots. Lung viral titer was
measured using qRT-PCR and shown as relative titer in log scale (Mean ± SEM). Values without same over bar label are
statistically different from each other (p<0.05).
doi: 10.1371/journal.pone.0076491.g009
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low level even with virus inoculation. Whether IL-6 over-
production was directly induced by H. perforatum extract
treatment or indirectly as a compensation for the interfered
IL-6R signaling cascade remains unknown.
The animal studies provided information regarding the
overall impact of H. perforatum extract treatment during
influenza virus inoculation. When the viral titer of inoculum was
low (105.0 EID50) and illness was mild, no significant change in
body weight and food and water consumption of mice was
seen in the H. perforatum extract treated group (Figure 3). BAL
IL-6 was elevated by H. perforatum extract treatment (Table 1),
consistent with the A549 cell response described above.
Because macrophage and monocyte infiltration usually reach
peak levels between 5-10 days post inoculation of influenza
virus, the higher percentage of BAL pulmonary mononuclear
phagocytes found in H. perforatum extract treated mice may
indicate a shift of the phagocyte exudation timeline or an
overall larger recruited phagocyte population into the lung
(Figure 5) [33-35]. Overall, H. perforatum extract treatment did
not ameliorate influenza virus infection when viral dose was at
a level of 105.0 EID50.
Our next effort was to increase viral dose to inflict more
severe influenza conditions in mice in anticipation of being able
to see more significant impact of the H. perforatum extract.
Under a high viral titer of 107.9 EID50 (>50% mortality dose),
mice became sick earlier and demonstrated steeper body
weight loss in the 5-day infection study (Figure 6). Although
there was a trend of lower body weight and food intake for the
H. perforatum treated group, the 5-day duration was not long
enough to show any significant effect of the treatment.
Interestingly, lung viral titer was significantly higher in the mice
that received H. perforatum extract, suggesting less efficient
viral clearance (Figure 4). The analysis of BAL cell populations
at the end of the 5-day study indicated higher amount of pro-
inflammatory neutrophils, macrophages, and monocytes, and
lower amount of CD8β+ cells in the H. perforatum extract
treatment group (Figure 7). This profile, together with the
corresponding increase of most major pro-inflammatory BAL
cytokines, chemokines and NO, indicated more severe
inflammation resulted from H. perforatum treatment (Table 2).
The only exception was the reduction of IP-10 level in the BAL
that could have resulted from the lower number of T cells,
which are known to stimulate IP-10 production through IFN-γ.
This ‘pro-inflammatory’ phenomenon was contrary to the in
vitro anti-inflammatory finding previously observed. A likely
explanation is that an early innate-immune inhibitory effect of
H. perforatum interfered with the necessary anti-viral host
response. Lung SOCS3 expression was found to be increased
after virus inoculation and further potentiated by the H.
perforatum extract treatment. It is possible that the increased
expression of SOCS3 by the extract inhibited innate immune
response and delayed subsequent viral clearance by CTLs,
resulting in higher viral titer by day 5 PI and more severe virus-
induced inflammation, although the majority of CTLs usually
enter the lung later than this time point [18]. Nonetheless,
whether these changes in BAL reflected overall detrimental
impact from the extract remains doubtful, especially given that
neutrophils could ameliorate lung injury during influenza and
monocyte/macrophages are important for anti-viral immunity
[6,36]; and considering that that the timing of neutrophil or
monocyte recruitment is probably important in determining
whether increases in these cell populations is beneficial or
detrimental. When the duration of study was extended, high
viral titer inoculation (107.9 EID50) combined with H. perforatum
Figure 10.  RNA transcription profiles the lung of BALB/c mice.  Expression levels of SOCS3 relative to GAPDH in lungs
collected at the end of the 5-day high viral titer inoculation study (107.9 EID50, N=15 for inoculated groups and N=6 for non-inoculated
group) and 10-day low viral tier inoculation study (105.1 EID50, N=13 for each group) were measured and shown as log relative
transcription level (Mean ± SEM). Values at the same time point are differentiated by individual over bar labels when significant
differences were found (p<0.05). ND=not determined (no non-inoculated group in the 10 day study).
doi: 10.1371/journal.pone.0076491.g010
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 extract treatment led to earlier and steeper decline of survival
curve (Figure 11), indicating that the altered immune response
could be detrimental to survival in severely infected animals.
During the early phase of influenza virus infection
inflammation is critical for viral containment and immune
activation [2]. But in the later phase, once the viral load has
been significantly decreased, anti-inflammatory intervention
may help reduce tissue damage. This hypothesis drove us to
the 10-day low viral titer (105.1 EID50) inoculation study, in which
H. perforatum extract was not administrated until 5 days PI.
The histopathological evaluation of lung tissues did not reveal
any lung lesion improvement associated with H. perforatum
extract treatment in the inoculated group. However, the viral
titer was slightly lower in the H. perforatum extract treated
group by day 10 PI, which could result from its anti-viral activity
as reported by Liu et al. [25]. Other than that, our study failed to
find any protective effect of late phase administrated H.
perforatum extract against influenza virus induced inflammatory
damage.
In conclusion, our study revealed an immune-regulatory
impact of H. perforatum extract, which appeared to impair
immune defense rather than inhibit inflammation during
influenza virus infection. The lower survival rate observed
among mice fed with H. perforatum extract confirmed the
potential contraindication of using H. perforatum during severe
influenza illness. The elevated SOCS3 associated with the
extract deserves further investigation, as it could be facilitating
viral invasion by interfering with innate immune regulation as
depicted in Figure 12.
Figure 11.  Survival curves of BALB/c mice inoculated with high viral titer.  Kaplan-Meier survival curves of mice that received
H. perforatum extract or 5% ethanol vehicle control, with or without intranasal inoculation of H1N1 influenza (107.9 EID50) are shown
(N=20 for each of the inoculated group, N=5 for the non-inoculated group). Curves with different letter annotation are significantly
different from each other (P<0.05).
doi: 10.1371/journal.pone.0076491.g011
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Figure 12.  Schematic diagram for the proposed underlying mechanism.  SOCS3 was a negative regulator that undermines
innate immunity against influenza virus infection. H. perforatum extract elevated SOCS3, and thus impaired the required anti-viral
immune defense system, resulting in uncontrolled infection and sustained inflammation.
doi: 10.1371/journal.pone.0076491.g012
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Supporting Information
Figure S1.  Cell viability with virus challenge and H.
perforatum extract treatment. Cell viability was measured by
MTS reagent at the time of harvesting supernatant. Results are
shown as percentage of not challenged vehicle control (Mean ±
SEM, N=3).
(TIF)
Figure S2.  Mouse serum cytokine levels in the 6 day low
viral titer inoculation study. Mice were inoculated with H1N1
virus (105.0 EID50) on day 0 and gavaged with 5% ethanol
vehicle control from day -1 to day 5 (N=12), or inoculated with
H1N1 virus on day 0 and gavaged with 110 mg/kg H.
perforatum extract (N=12), or not inoculated by virus and
gavaged with 5% ethanol (N=6). Serum IL-6 (A) and IL-1β (B)
were measured using ELISA and shown as Mean ± SEM.
Values without same label are different from each other
statistically (p<0.05).
(TIF)
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